BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29550606)

  • 21. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion.
    Biswas D; Bible JE; Whang PH; Miller CP; Jaw R; Miller S; Grauer JN
    Am J Orthop (Belle Mead NJ); 2010 Nov; 39(11):531-8. PubMed ID: 21623419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.
    Brecevich AT; Kiely PD; Yoon BV; Nguyen JT; Cammisa FP; Abjornson C
    Spine J; 2017 Jun; 17(6):855-862. PubMed ID: 28126356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
    Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
    Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
    Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
    Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
    Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Percutaneous Posterolateral Spinal Fusion With Recombinant Bone Morphogenetic Protein-2 (rhBMP-2): A Comparison With Standard Methods Using an Animal Model Study.
    Chan CY; Kwan MK; Saw LB; Paisal H
    Clin Spine Surg; 2017 Mar; 30(2):E138-E147. PubMed ID: 28207623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-based Difference in Response to Recombinant Human Bone Morphogenetic Protein-2 in a Rat Posterolateral Fusion Model.
    Foley JP; Fred EJ; Minardi S; Yamaguchi JT; Greene AC; Furman AA; Lyons JG; Paul JT; Nandurkar TS; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Hsu WK; Stock SR; Hsu EL
    Spine (Phila Pa 1976); 2022 Dec; 47(23):1627-1636. PubMed ID: 35943241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
    Kong CB; Lee JH; Baek HR; Lee CK; Chang BS
    Spine J; 2014 Dec; 14(12):2959-67. PubMed ID: 24937799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting.
    Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR
    Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model.
    Hsu WK; Wang JC; Liu NQ; Krenek L; Zuk PA; Hedrick MH; Benhaim P; Lieberman JR
    J Bone Joint Surg Am; 2008 May; 90(5):1043-52. PubMed ID: 18451397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth.
    Patel VV; Zhao L; Wong P; Pradhan BB; Bae HW; Kanim L; Delamarter RB
    Spine J; 2006; 6(4):397-403; discussion 404. PubMed ID: 16825045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model.
    Morimoto T; Kaito T; Matsuo Y; Sugiura T; Kashii M; Makino T; Iwasaki M; Yoshikawa H
    Spine J; 2015 Jun; 15(6):1379-90. PubMed ID: 25733023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel application of high-dose (50kGy) gamma irradiation for demineralized bone matrix: effects on fusion rate in a rat spinal fusion model.
    Alanay A; Wang JC; Shamie AN; Napoli A; Chen C; Tsou P
    Spine J; 2008; 8(5):789-95. PubMed ID: 17996496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.